Humana Inc. (NYSE:HUM) Position Boosted by Everence Capital Management Inc.

Everence Capital Management Inc. lifted its position in shares of Humana Inc. (NYSE:HUM) by 4.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 4,370 shares of the insurance provider’s stock after acquiring an additional 170 shares during the quarter. Everence Capital Management Inc.’s holdings in Humana were worth $2,001,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the business. Gradient Investments LLC grew its position in shares of Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after buying an additional 40 shares during the last quarter. Sunbelt Securities Inc. bought a new stake in shares of Humana in the 1st quarter worth approximately $28,000. Householder Group Estate & Retirement Specialist LLC bought a new position in Humana during the 3rd quarter worth $39,000. Nvwm LLC lifted its stake in Humana by 41.0% in the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after buying an additional 25 shares during the last quarter. Finally, Turtle Creek Wealth Advisors LLC acquired a new position in shares of Humana during the fourth quarter valued at $55,000. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on HUM shares. Mizuho decreased their target price on shares of Humana from $550.00 to $400.00 and set a “buy” rating for the company in a research report on Friday, January 26th. Cantor Fitzgerald reiterated a “neutral” rating and set a $391.00 price target on shares of Humana in a research report on Wednesday, April 10th. Barclays cut their price objective on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. Raymond James started coverage on shares of Humana in a research note on Friday, March 22nd. They set a “market perform” rating on the stock. Finally, Truist Financial restated a “hold” rating and issued a $550.00 target price on shares of Humana in a research report on Friday, January 19th. Eleven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $465.42.

Insider Buying and Selling at Humana

In other news, Director Jorge S. Mesquita acquired 545 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was acquired at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the acquisition, the director now owns 2,578 shares in the company, valued at $946,358.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.29% of the company’s stock.

Humana Price Performance

HUM stock opened at $317.42 on Wednesday. The firm has a 50-day moving average of $345.31 and a two-hundred day moving average of $426.43. The firm has a market capitalization of $38.30 billion, a PE ratio of 16.02, a P/E/G ratio of 1.84 and a beta of 0.45. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. Humana Inc. has a one year low of $299.23 and a one year high of $541.21.

Humana (NYSE:HUM) last announced its earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.87). Humana had a net margin of 2.34% and a return on equity of 19.44%. The firm had revenue of $26.46 billion for the quarter, compared to analyst estimates of $25.47 billion. During the same period last year, the firm earned $1.62 earnings per share. Humana’s revenue for the quarter was up 17.9% compared to the same quarter last year. On average, analysts forecast that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.12%. The ex-dividend date is Wednesday, March 27th. Humana’s dividend payout ratio is currently 17.86%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.